Polymerase Chain Reactions (PCR) Devices, Reagents and Uses Global Market Report 2024

The polymerase chain reactions (pcr) devices, reagents and uses market size has grown strongly in recent years. It will grow from $5.9 billion in 2023 to $6.19 billion in 2024 at a compound annual growth rate (CAGR) of 5.0%. Historical growth can be attributed to several key factors, including the escalating prevalence of infectious diseases, a surge in demand for clinical diagnostic services, an increasing need for personalized medicine, and the widespread adoption of PCR technology in research and development endeavors. These elements collectively drove the growth observed in the past period within the PCR industry.

The polymerase chain reactions (pcr) devices, reagents and uses market size is expected to see strongly grown in the next few years. It will grow to $8.25 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. Anticipated growth in the upcoming period is linked to various factors such as the ongoing monitoring of COVID-19 and infectious diseases, advancements in cancer diagnostics particularly through liquid biopsies, expanded applications in agriculture and environmental sectors, the growing scope of pharmacogenomics, and ongoing advancements in genomic research.

The surge in infectious diseases worldwide is a key driver behind the expanding polymerase chain reaction (PCR) devices and reagents market. These devices play a pivotal role in clinical laboratories by detecting infectious disease presence. Reports from the World Health Organization indicate a staggering toll of 17 million deaths annually due to infectious diseases, with 30 new diseases emerging in the last two decades. In the United States alone, 15.5 million people sought medical attention from physicians for infectious diseases, fueling the demand for clinical diagnostic services and propelling the PCR devices and reagents market.

The burgeoning pharmaceutical industry is poised to catalyze growth in the PCR devices, reagents, and applications market. As a key player in healthcare, the pharmaceutical sector is heavily involved in drug research, development, manufacturing, and marketing. Its engagement in drug development, diagnostics, quality control, and personalized medicine fosters diverse applications for PCR devices and reagents. In 2021, Americans spent $576.9 billion on prescription drugs, with an anticipated expenditure of $605 to $635 billion on medical care in the US by 2025, as reported by Cross River Therapy. The pharmaceutical industry's expansion is thus a driving force behind the growth of PCR devices, reagents, and their multifaceted uses. Companies in the PCR devices and reagents market are increasingly directing attention toward Digital PCR due to its heightened accuracy compared to conventional methods. Digital PCR offers a comprehensive evaluation of nucleic acids without relying on standard curves, expanding upon traditional techniques. Leading entities investing in digital polymerase chain reaction technology include BioRad Technologies, Atlas Genetics, OriGene Technologies, STST-Diagnostica, Ugen Tec, and Genesis Healthcare Company.

Major players in the PCR devices, reagents, and applications market are innovating new products like IsoFast Bst Polymerase reagents to bolster their market position. These reagents, launched by PCR Biosystems Ltd. In March 2021, enable thermocycling-free, rapid, reliable, and sensitive amplification of DNA and RNA targets. Suitable for various amplification techniques like loop-mediated isothermal amplification (LAMP) and whole genome amplification, the IsoFast Bst Polymerase reagents incorporate a 2-part buffer solution, enhancing yield and performance even in challenging conditions, exemplifying advancements in PCR technology.

Major companies operating in the polymerase chain reactions (PCR) devices, reagents and uses market include Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Becton Dickinson and Company, Abbott Laboratories, bioMérieux S.A., Agilent Technologies Inc., QIAGEN N.V., Siemens Healthcare GmbH (Siemens AG), Fluidigm Corporation, SYGNIS Pharma AG, Takara Bio Inc., Cepheid, Lontech Laboratories, Eppendorf India Private Limited, GE Healthcare, Kapa Biosystems, Maxim Biomedical Inc., Promega Corporation, RainDance Technologies Inc., Affymetrix Inc., Beckman Coulter Inc., Enzo Life Sciences Inc., Roche Diagnostics GmbH, Merck KGaA, Danaher Corporation, Stilla Technologies, Meridian Bioscience Inc., BioFire Diagnostics LLC, Luminex Corporation, GenMark Diagnostics Inc.

North America was the largest region in the polymerase chain reactions (PCR) devices and reagents market in 2023. Western Europe was the second-largest region in the global polymerase chain reactions (PCR) devices and reagents market report. The regions covered in the polymerase chain reactions (PCR) devices, reagents and uses market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the polymerase chain reactions (PCR) devices, reagents and uses market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada. The polymerase chain reactions (PCR) devices and reagents market consists of sales of conventional PCR machines, qPCR, reverse transcription PCR, nested PCR, hot start PCR, and digital PCR devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The primary products within PCR devices and reagents include instruments, reagents, and consumables. Instruments refer to tools or devices designed for specific tasks. Varieties of instruments utilized include standard PCR, rt-PCR (reverse transcription PCR), and digital PCR. These products find application across diverse end-users such as the pharmaceutical and biotechnology industries, clinical diagnostics labs, hospitals, academic institutions, and research organizations.

The polymerase chain reactions (PCR) devices and reagents market research report is one of a series of new reports provides polymerase chain reactions (PCR) devices and reagents market statistics, including polymerase chain reactions (PCR) devices and reagents industry global market size, regional shares, competitors with a polymerase chain reactions (PCR) devices and reagents market share, detailed polymerase chain reactions (PCR) devices and reagents market segments, market trends and opportunities, and any further data you may need to thrive in the polymerase chain reactions (PCR) devices and reagents industry. This polymerase chain reaction (PCR) devices and reagents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.